Drug factory · FDA FEI 3002806661

Changzhou Pharmaceutical Factory

No.518 Laodong East Road, Changzhou, China

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 12, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2009: 2 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CaptoprilMakes it AiPing Pharmaceutical, Inc. 11788-135, 11788-136, 11788-137 +1
DoxycyclineMakes it AiPing Pharmaceutical, Inc., Bi-Coastal Pharma International LLC, Changzhou Pharmaceutical Factory, Cranbury Pharmaceuticals, LLC 11788-134, 42582-216, 55488-0185 +2
LevetiracetamMakes it and tests it Changzhou Pharmaceutical Factory, Omnivium Pharmaceuticals Llc. 55488-0519, 81665-100, 81665-101
PregabalinMakes it Tris Pharma Inc 27808-235, 27808-236, 27808-237 +4
RivaroxabanMakes it Changzhou Pharmaceutical Factory 55488-0540, 55488-0541, 55488-0542
RosuvastatinMakes it, tests it, packages it and labels it Cranbury Pharmaceuticals, LLC 27808-155, 27808-156, 27808-157 +1
TicagrelorMakes it Bionpharma Inc., Changzhou Pharmaceutical Factory 69452-508, 69452-509, 55488-0543 +1

FDA inspection history

EndedResultProgramProblems noted
Jan 12, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 25, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 23, 2017No problems foundDrug Quality Assurance—
May 20, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 9, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 2, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.